Does Phaster Mean Better?(Editorial) Does Phaster Mean Better?(Editorial)

Does Phaster Mean Better?(Editorial‪)‬

Clinical Chemistry 1997, March, 43, 3

    • 2,99 €
    • 2,99 €

Publisher Description

The accelerated pace of discovery of disease-causing genes has made efficient mutation detection a priority. Identification of DNA sequence variants allows human geneticists to determine, among other things, whether a candidate gene contributes to disease susceptibility, to identify new alleles at known loci, and to develop molecular diagnostic tests. Once a susceptibility gene has been identified, the investigator interested in molecular diagnostics or genotype-phenotype correlation must decide how to perform rapid, sensitive detection of mutations. Grompe [1] divided these techniques into those that are most useful for identifying known mutations and those that are better for detecting novel mutations. However, he also allowed that no one method would be appropriate for all situations. Clearly, the choices investigators make will be based, in part, on what they are trying to accomplish (e.g., diagnostics vs population studies of allele frequencies); the goal will also dictate the level of sensitivity required and, conversely, the proportion of false positives or negatives that can be tolerated. Other factors such as knowledge of genomic size, sequence, and structure; availability of RNA/cDNA; and access to equipment and technical expertise will also influence the decision.

GENRE
Science & Nature
RELEASED
1997
1 March
LANGUAGE
EN
English
LENGTH
11
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
152.7
KB
Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor) Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor)
2002
Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report) Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report)
2008
Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss (Molecular Diagnostics and Genetics) Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss (Molecular Diagnostics and Genetics)
2003
Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology) Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology)
2004
Metabolic, Nutritional, Iatrogenic, And Artifactual Sources of Urinary Organic Acids: A Comprehensive Table. Metabolic, Nutritional, Iatrogenic, And Artifactual Sources of Urinary Organic Acids: A Comprehensive Table.
2002
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997